SEC Form 4 · accession 0001209191-16-154015
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Petrus Bekker
Officer — Chief Medical Officer
Period of report
Dec 5, 2016
Accepted (ET)
Dec 7, 2016 · 7:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 5, 2016 | M | 30,000 | $6.00 | A | 83,594 | D | |
| Common Stock | Dec 5, 2016 | S | 30,000 | $8.50 | D | 53,594 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $6.00 | Dec 5, 2016 | M | 30,000 | D | Feb 17, 2009 | Feb 17, 2019 | Common Stock | 30,000 | 14,168 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2As of December 5, 2016 and prior to this transaction, the option fully vested.
- F3Not applicable.